| 1 | 151319-34-5 | 扎来普隆* | Zaleplon | C17H15N5O
| 药物;镇静催眠药;中枢神经系统用药 | |
| 2 | 1527473-33-1 | PF-06447475 | PF-06447475 | C17H15N5O
| 抑制剂;小分子抑制剂;小分子抑制剂，天然产物 | |
| 3 | | BUTTPARK 53\40-82 | BUTTPARK 53\40-82 | C17H15N5O
| | |
| 4 | | BUTTPARK 123\49-60 | BUTTPARK 123\49-60 | C17H15N5O
| | |
| 5 | 2410195-20-7 | 伊马替尼杂质K | Imatinib Impurity K | C17H15N5O
| 对照品-杂质对照品 | |
| 6 | 851137-91-2 | 尼罗替尼杂质17 | NILOTINIB IMPURITY 17 | C17H15N5O
| 杂质对照品 | 杂质对照品 |
| 7 | | N-[4-(2-AMINOPYRIMIDIN-4-YL)PHENYL]-N'-PHENYLUREA | N-[4-(2-AMINOPYRIMIDIN-4-YL)PHENYL]-N'-PHENYLUREA | C17H15N5O
| | |
| 8 | | 5-(4-(phenylmethoxy)phenyl)-2-(2-cyanoethyl)tetrazole | 5-(4-(phenylmethoxy)phenyl)-2-(2-cyanoethyl)tetrazole | C17H15N5O
| | |
| 9 | | N-ALLYL-4-[4-(PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]BENZAMIDE | N-ALLYL-4-[4-(PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL]BENZAMIDE | C17H15N5O
| | |
| 10 | 140215-50-5 | But-3-en-2-one, 4-phenylamino-3-(1-phenyl-5-tetrazolyl)- | But-3-en-2-one, 4-phenylamino-3-(1-phenyl-5-tetrazolyl)- | C17H15N5O
| | |
| 11 | 478046-67-2 | N-(4-METHYLPHENYL)-N'-[2-(3-PYRIDINYL)-4-PYRIMIDINYL]UREA | N-(4-METHYLPHENYL)-N'-[2-(3-PYRIDINYL)-4-PYRIMIDINYL]UREA | C17H15N5O
| | |
| 12 | 130019-22-6 | 2H-Tetrazole-2-propanenitrile, 5-(4-(phenylmethoxy)phenyl)- | 2H-Tetrazole-2-propanenitrile, 5-(4-(phenylmethoxy)phenyl)- | C17H15N5O
| | |
| 13 | 330820-17-2 | 3-methoxybenzaldehyde (5-phenyl-1,2,4-triazin-3-yl)hydrazone | 3-methoxybenzaldehyde (5-phenyl-1,2,4-triazin-3-yl)hydrazone | C17H15N5O
| | |
| 14 | | N-{(1E)-AMINO[(4-METHYLQUINAZOLIN-2-YL)AMINO]METHYLENE}BENZAMIDE | N-{(1E)-AMINO[(4-METHYLQUINAZOLIN-2-YL)AMINO]METHYLENE}BENZAMIDE | C17H15N5O
| | |
| 15 | | 4-[1-(2-METHYLBENZYL)-1H-BENZIMIDAZOL-2-YL]-1,2,5-OXADIAZOL-3-AMINE | 4-[1-(2-METHYLBENZYL)-1H-BENZIMIDAZOL-2-YL]-1,2,5-OXADIAZOL-3-AMINE | C17H15N5O
| | |
| 16 | 478081-98-0 | N-(3-(3-Cyanopyrazolo[1,5-α]pyrimidin-5-yl)phenyl)-N-ethylacetamide | N-(3-(3-Cyanopyrazolo[1,5-α]pyrimidin-5-yl)phenyl)-N-ethylacetamide | C17H15N5O
| | |
| 17 | 957480-37-4 | N'-[(4-methyl-1-phenyl-1H-pyrazol-3-yl)methylene]isonicotinohydrazide | N'-[(4-methyl-1-phenyl-1H-pyrazol-3-yl)methylene]isonicotinohydrazide | C17H15N5O
| | |
| 18 | 1285532-43-5 | (E)-N-(pyridin-2-ylmethylene)-3-(p-tolyl)-1H-pyrazole-5-carbohydrazide | (E)-N-(pyridin-2-ylmethylene)-3-(p-tolyl)-1H-pyrazole-5-carbohydrazide | C17H15N5O
| | |
| 19 | | 1-(2-{[2-(1-phenyl-1H-1,2,3,4-tetraazol-5-yl)vinyl]amino}phenyl)ethan-1-one | 1-(2-{[2-(1-phenyl-1H-1,2,3,4-tetraazol-5-yl)vinyl]amino}phenyl)ethan-1-one | C17H15N5O
| | |
| 20 | | (4Z)-3,4-Dihydro-3-methyl-4-[(2-acetylphenylazo)methylene]-1,2,3-benzotriazine | (4Z)-3,4-Dihydro-3-methyl-4-[(2-acetylphenylazo)methylene]-1,2,3-benzotriazine | C17H15N5O
| | |
| 21 | 1043908-08-2 | 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-methyl-3-m-tolyl-1H-imidazol-2(3H)-one | 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-methyl-3-m-tolyl-1H-imidazol-2(3H)-one | C17H15N5O
| | |
| 22 | | (1E,2E)-3-(2-FURYL)-2-METHYLACRYLALDEHYDE (5-PHENYL-1,2,4-TRIAZIN-3-YL)HYDRAZONE | (1E,2E)-3-(2-FURYL)-2-METHYLACRYLALDEHYDE (5-PHENYL-1,2,4-TRIAZIN-3-YL)HYDRAZONE | C17H15N5O
| | |
| 23 | 665001-26-3 | 6-amino-3-ethyl-4-(1H-indol-3-yl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | 6-amino-3-ethyl-4-(1H-indol-3-yl)-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | C17H15N5O
| | |
| 24 | | 4-[(2-Oxopyrimidin-1-yl)amino]-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-d]pyrimidine | 4-[(2-Oxopyrimidin-1-yl)amino]-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-d]pyrimidine | C17H15N5O
| | |
| 25 | | 6-amino-8-(3-furyl)-2-methyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile | 6-amino-8-(3-furyl)-2-methyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile | C17H15N5O
| | |